In oncology pharmacology, how does first-line therapy differ from adjuvant therapy?

• A. First-line is the initial standard treatment; adjuvant is additional therapy after primary treatment to erase residual disease.
• B. Adjuvant therapy is the initial standard treatment; first-line is additional therapy after primary treatment.
• C. First-line therapy includes only surgical approaches.
• D. Adjuvant therapy is experimental therapy used in trials.

Answer: (A)

This question hinges on when a therapy is given and why. First-line therapy is the initial standard treatment you give when the cancer is diagnosed, with the aim of controlling the disease and extending survival. Adjuvant therapy, on the other hand, is added after the primary local treatment (often surgery) to kill any microscopic cancer cells that may remain and to reduce the risk of recurrence.

In practice, a patient might have surgery to remove a tumor and then receive adjuvant chemotherapy, hormonal therapy, radiation, or targeted therapy to mop up residual disease. Neoadjuvant therapy, which is given before the primary treatment to shrink the tumor, is a related concept but distinct from adjuvant therapy.

So the statement that first-line therapy is the initial standard treatment and adjuvant therapy is additional treatment after the primary treatment to erase residual disease captures the correct distinction. The other descriptions don’t fit because adjuvant therapy is not the initial standard treatment, it’s the follow-up aimed at eradicating remaining cancer cells, and it isn’t limited to surgery or to experimental use.